Join the Portal
Contact UsKnown Compounds
Obtain Marketed or Active Investigational Compounds
To request compounds based on mechanism of action or desired
target effect, please submit your proposal via the Portal.
To request marketed compounds or investigational compounds in
active development, please use the following resources.
Pfizer
Pfizer has an extensive pure powder gift program that encompasses
all of our publicly known compounds. The program is a two-tier
system that includes the legal and scientific branches of our
company. As a responsibility to the share holders and the future of the
company the legal branch requires specific intellectual protection on
all compounds that are provided to third parties. This protection also
provides Pfizer with a non exclusive license to any invention found that
requires the Pfizer compound to function. The scientific branch is
responsible to review each request for it content, value, and to ensure
that the study is consistent with Pfizer's direction for the requested
compound. When both branches agree, the compound is provided,
free of charge to the third party to conduct the agreed upon study.
Pfizer also reserves the right to deny any request that we feel does not
advance our compound(s) or add value to human or animal health.
Finally after one year of receipt of the compound or completion of the
study, which ever occurs first, a manuscript or report of the
conclusions are required to bring closure to the study. To request a Pfizer compound please complete the attached
compound request form. This form will provide Pfizer with the
minimum information required to issue our required Compound
Transfer Agreement, (CTA). The CTA is the legal document that
details what you can and cannot do with the requested compound(s).
The CTA also stipulates Intellectual property rights for Pfizer if a new
invention is made that requires the Pfizer compound. Along with the
CTA a Statement of Investigation, (SOI) will be enclosed. When
completing The SOI it needs to be a specific and detailed description
of your proposed study. The completed SOI is the document used to
review and approve or deny your request. From initial contact to the
approved compound(s) arriving at your facility is normally 12 weeks.
Pfizer Compound Transfer Program for Preclinical Studies
Pfizer Compounds for Clinical Studies (Investigator Initiated
Research)
Pfizer Compound Request Form for Preclinical Studies
Pfizer contact:
Donnie W. Owens
Pfizer Compound Transfer Manager
Worldwide Strategic Alliances
Pfizer Inc
MS 8200-30
Eastern Point Road
Groton, CT 06430
Phone (860) 441-8201
Fax (860) 441-1300
Email: donnie.w.owens@pfizer.com
Merck
Merck IISP program is designed to transfer marketed or active investigational compounds. Please stay tuned for more instructions on how to submit your request to IISP.
For other compounds contact:
Dr. Yael Weiss
Director, Licensing and External Research, West Coast
Merck
7825 Fay Avenue, Suite 320, La Jolla, CA 92118
yael_weiss@merck.com
GSK
Complete the factsheet for external investigators to request GSK research compounds (some questions may not apply) and return with a 1-2 paragraph statement of intended research.
GSK Contact:
Jane L. Oakley
Compound Management RTF
Fax: 919-483-5695
Jane.L.Oakley@GSK.com
Novartis
Novartis contact:
Andrea Khoshdel
Head, Material Transfer Management
Novartis Pharma AG
NIBR - GRM
Forum 1, Novartis Campus
WSJ-386.12.06-10
CH-4056 Basel
Switzerland
Phone: +41 61 32 ext. /43848/40541/45425/43807
Fax: +41 61 32 43993
Email: MTM.basel@novartis.com
Complete the Study Proposal Form
Genentech
This Program is solely to coordinate transfer for pre-clinical, non-
human studies.
Compound Transfer Program
Abbott
Contact:
Michelle A Parks, J.D.
Sr. Manager, Technology Licensing
Global Pharmaceutical Licensing & New Business Development
Abbott
200 Abbott Park Road
P50A, AP34-2
Abbott Park, IL 60064
USA
Phone 847-938-0579
Fax 847-937-1771
michelle.parks@abbott.com
AstraZeneca
Contact:
Christopher Yochim
Director, External Relations
Strategic Planning and Business Development
AstraZeneca
chris.yochim@astrazeneca.com
Eli Lilly
The established way to obtain Lilly samples or compounds for external investigators is to contact our call center, The Lilly Answer Center, at 1800 LillyRx ( 1 800-545 5979) and submit the request to one of our call agents. The request will then be forwarded to the appropriate department for further processing.